Hamostaseologie

Article	Citations
Erratum: Effect of DDAVP on Platelet Activation and Platelet-Derived Microparticle Generation	156
Association of Thrombin-Activatable Fibrinolysis Inhibitor with Acute Pulmonary Embolism	62
Simply Online? Lessons from Virtual Scientific Conferences for the Post-COVID-19 Era	54
GTH 2025 ARTE: The Art in Science – Curiosity and Creativity	35
COVID-19: Cardio-pulmonary and Vascular Manifestations	22
COVID-19 as a Potential Trigger for Immune Thrombotic Thrombocytopenic Purpura and Reason for an Unusual Treatment: A Case Report	22
Gründung des Fachausschusses für das Deutsche Hämophilieregister (DHR) und Medizinische Informationsobjekte (MIO)	17
Inherited Platelet Disorders: A Short Introduction	17
Theme Issue: “Critical Management Decisions in Hemostasis and Thrombosis”	17
Treatment of Atypical Clots	14
COVID-19 Presented with Deep Vein Thrombosis in a Patient with Paroxysmal Nocturnal Haemoglobinuria	13
Comparison of Performances among Four Bleeding-Prediction Scores in Elderly Cancer Patients with Venous Thromboembolism	13
Probleme der Digitalisierung sowie Protest gegen das Finanzstabilisierungsgesetz	13
GTH News	12
Novel Likely Pathogenic Variant in the A3 Domain of von Willebrand Factor Leading to a Collagen-Binding Defect	12
	11
Anticoagulation in Critically Ill Adults during Extracorporeal Circulation	11
Hemostaseology in Pediatrics	10
Veranstaltung des BDDH am 03.03.2022 im Rahmen der 66. Jahrestagung der Gesellschaft für Thrombose- und Hämostaseforschung (GTH) in Leipzig	10
Haemostaseological pearls	9
	9
Transfusion älterer Erythrozyten erhöht Mortalität und Thromboembolie-Risiko	9
	8
Identification of novel cryptic epitopes uncovers a distinct and consistent open ADAMTS13 conformation in iTTP	7
GTH News	7

Global Coagulation Testing in Acute Care Medicine: Back to Bedside?	7
Fachgespräche zur Plasma-Versorgung in Deutschland und Sachstand zur neuen Gebührenordnung für Ärzte (GOÄ)	7
Increasing Use of Anticoagulants in Germany and Its Impact on Hospitalization for Tooth Extraction	7
Thromboinflammation as a Driver of Venous Thromboembolism	7
Novel heterozygous termination variants causing von Willebrand disease type 1	6
Mim8 Prophylaxis Beyond Bleeding: Investigating Multifaceted, Patient-reported Outcomes for Hemophilia A in the FRONTIER2 Study	6
Platelet Phosphoproteomic Profile Behind Anti-thrombotic Effects of Atypical Chemokine Receptor ACKR3	6
ITAM upregulation in platelets after major surgery	6
Determination of thrombotic risk in patients with antiphospholipid syndrome using a modified thrombin generation assay	6
A novel assay to quantify extrinsic tenase complexes in body fluids	5
Asundexian and milvexian: Pharmacodynamic insights from coagulation assays	5
The change in factor VIII therapy in Germany - a follow-up retrospective data analysis from smart medication ScanDoc over four years	5
The dynamic range of immunoassays for heparin-induced thrombocytopenia	5
Platelet-dependent hemostatic potential in the presence of DOACs	5
Assessment of plasma levels of D-dimer and prothrombin fragment 1+2 in patients on direct oral anticoagulants versus vitamin K antagonists	5
Aspects of long-term joint health in haemophilia A: inSight Joint Health tool	4
Real-World Effectiveness and Usage of Recombinant Factor IX Fc: Interim Analysis in Paediatric Patients from the 24-Month, Prospective, Non-Interventional B-MORE Study	4
Hemophilia B Leyden: Characteristics and natural history in the PedNet Registry	4
Platelet activating histone/anti-histone immune complexes are associated with a new entity of thrombosis and thrombocytopenia syndrome	4
One year practical experience in factor VIII gene therapy	4
Characteristics of patients with bleeding disorder of unknown cause in a cohort of patients with mild to moderate bleeding disorders	4
Plasma factors might interfere with platelet function in patients with decompensated liver cirrhosis	4
Emicizumab Real-World Use in Pediatric Patients: Insights from the German GEPHARD Registry	4
Comparing thrombin generation in hemophilia A and patients with non-valvular atrial fibrillation on oral anticoagulation	4
Cold-storage of amotosalen-UVA pathogen-reduced buffy-coat platelet concentrates for up to 21 days: identification of emerging platelet subpopulations with different functional potential	3
Anticoagulation Therapy in Cancer Patients with Thrombosis in the Outpatient Sector of Germany (The CERTIFICAT Initiative)—German Practice of Anticoagulation Therapy of Cancer Patients with Thrombosis	3
Consensus Recommendations for Intramuscular COVID-19 Vaccination in Patients with Hemophilia	3
Übergewicht und Adipositas erhöht Risiko für venöse Thromboembolien	3
Combining Diagnostics and Research in an Academic Laboratory	3
Tolerance Breakdown in Hemophilia A Mice is Orchestrated by Bacterial Infection Modulating Antigen-Specific B and T cell Responses	3
Investigating the impact of oligogenic variation on severity of bleeding in hypofibrinogenemia	3
Damoctocog Alfa Pegol in German Patients With Severe and Non-Severe Haemophilia A: Fifth Interim Analysis of the Real-World HEM-POWR Study	3
Basic Concepts and Indications of CAR T Cells	3
Evidence-Based Medicine: Principles and Values as Illustrated by the Case of Patient Blood Management	3
Emicizumab for All Pediatric Patients with Severe Hemophilia A	3
Update on the Use of Thrombopoietin-Receptor Agonists in Pediatrics	3
High Prevalence of Acquired Platelet Secretion Defects in Multiple Myeloma	3
Modification of fibrinolytic potential after cessation of combined oral contraceptives	3
Natural IgM antibodies reduce the prothrombotic potential of post-translationally modified collagen	3
A Review of FXIa Inhibition as a Novel Target for Anticoagulation	3
Interventional Treatment Options in Children with Extracranial Vascular Malformations	3
Geringe α-Thrombin/GPIbα-Interaktion trägt möglicherweise zur Hyperreaktivität der Thrombozyten bei COVID-19-Patienten bei	3
Current Topics from the Revised German S2k Guideline on Diagnosis and Treatment of Venous Thromboembolism	3
Aktueller Stand zur Reform der Gebührenordnung für Ärzte (GOÄ) und Veranstaltung des BDDH auf der 69. Tagung der Gesellschaft für Thrombose- und Hämostaseforschung (GTH) in Lausanne 2025	3
Massive portal vein thrombosis due to platelet-activating PF4 antibodies without proximate heparin exposure, infection, or SARS-CoV-2 vaccination	3
Feasibility of tests for sports motor skills (general fitness, proprioception and balance) in patients with hemophilia and association with pain and orthopedic joint status	3
Women and Hereditary Bleeding Disorders	3
	2
Medizinforschungsgesetz, Apothekenreform-Gesetz, Telemedizin Blutspende-Verordnung, Erweiterung der Dokumentationspflichten im Deutschen Hämophilieregister (DHR)	2
Assessment of Factor VIII Activity and D-Dimer Levels in the Post-COVID Period	2

Die Gesellschaft für Thrombose- und Hämostaseforschung e.V. informiert	2
Management of Disseminated Intravascular Coagulation in Acute Leukemias	2
Utility of Global Hemostatic Assays in Patients with Bleeding Disorders of Unknown Cause	2
100 Years of Thrombotic Thrombocytopenic Purpura: A Story of Death and Life	2
Platelet Reduction in Rats Exposed to Chronic Hypoxia Is Associated with Interaction of Glycoprotein Ib Alpha von Willebrand Factor	2
Insights into the Molecular Genetic of Hemophilia A and Hemophilia B: The Relevance of Genetic Testing in Routine Clinical Practice	2
Interim Analysis of Joint Outcomes in Adult and Adolescent Patients with Severe Hemophilia A Receiving Efanesoctocog Alfa During the Phase 3 XTEND-ed Long-Term Extension Study	2
PAS: Die Rolle von Natriumcitrat bei längerer Kaltlagerung von Thrombozyten	2
Arterial and Venous Thromboembolic Complications in 832 Patients with BCR-ABL-Negative Myeloproliferative Neoplasms	2
Efgartigimod hilft bei Immunthrombozytopenie	2
COVID-19 and Myocarditis: Findings from Cardiac Magnetic Resonance Imaging and Endomyocardial Biopsies	2
Anti-inflammatory Strategies in Atherosclerosis	2
Erratum: Aktueller Bericht der BDDH über die aktuellen gesundheitspolitischen Entwicklungen mit politischer Einordnung	2
Genetic Analysis of Hereditary Coagulation Factor V Deficiency in Two Chinese Families Caused by Compound Heterozygous Mutations	1
Treatment of Cancer-Associated Thrombosis: An Update	1
Platelets in Myocardial Ischemia/Reperfusion Injury	1
Immune Plasma for the Treatment of COVID-19: Lessons Learned so far	1
Expert Opinion for Defining a Severe Bleeding Phenotype to Guide Prophylaxis in Patients with Nonsevere Hemophilia	1
Nachtrag zur kritischen Diskussion über das Deutsche Hämophilieregister (DHR) anlässlich der GTH-Jahrestagung in Frankfurt 2023, aktuelle Informationen zur Gefährdung der Versorgung mit Blutplasmaprod	1
Update on Cancer-Associated Venous Thromboembolism in Children	1
Potentials of Endothelial Colony-Forming Cells: Applications in Hemostasis and Thrombosis Disorders, from Unveiling Disease Pathophysiology to Cell Therapy	1
Evaluation der Vertriebswegänderung und der gesetzlichen Folgeänderungen für Gerinnungsfaktorenzubereitungen; Digitalisierung im Gesundheitswesen: Elektronische Patientenakte; Aktueller Stand bzgl. ne	1
Thrombozytopenie: Sind Thrombozytentransfusionen vor Legen eines ZVK verzichtbar?	1
	1
Cancer-Associated Venous Thromboembolism—Diagnostic and Therapeutic Considerations: An Update Based on the Revised AWMF S2k Guideline	1
A Comparison of Activated Partial Thromboplastin Time and Activated Coagulation Time for Anticoagulation Monitoring during Extracorporeal Membrane Oxygenation Therapy	1
Komplementdysregulation als Biomarker für Post Covid	1
Mechanism, Functions, and Diagnostic Relevance of FXII Activation by Foreign Surfaces	1
Editorial	1
GTH News	1
Aktueller Bericht der BDDH über die aktuellen gesundheitspolitischen Entwicklungen mit politischer Einordnung	1
High Prevalence of Plasminogen Activator Inhibitor-1 4G/5G Polymorphism among Patients with Venous Thromboembolism in Kerala, India	1
Does a Simple Blood Gas Analysis and the Clinical Impression Predict Trauma-Induced Coagulopathy?	1
VTE Risk Assessment and Prevention in Pregnancy	1
Rectus Sheath Hematoma in a Patient with Dual-Antiplatelet Therapy Including Ticagrelor: A Case Report	1
Erratum: Diagnosis and Management of Vaccine-Related Thrombosis following AstraZeneca COVID-19 Vaccination: Guidance Statement from the GTH	1
iTTP in der Schwangerschaft: Erfolgreiche Behandlung mit Caplacizumab	1
Cardio-Oncology: A New Discipline in Medicine and Its Relevance to Hematology	1
The Current Evidence of Pulmonary Embolism Response Teams and Their Role in Future	1
Current Concepts of Pathogenesis and Treatment of Philadelphia Chromosome-Negative Myeloproliferative Neoplasms	1
Direct Oral Anticoagulants for Pulmonary Embolism	1
Pulmonary Hypertension and COVID-19	1
Integration of Extracorporeal Membrane Oxygenation into the Management of High-Risk Pulmonary Embolism: An Overview of Current Evidence	1
Die Gesellschaft für Thrombose- und Hämostaseforschung e.V. informiert	1
Recurrent Venous Thromboembolism in Patients on Anticoagulation: An Update Based on the Revised AWMF S2k Guideline	1
Post–Pulmonary Embolism Syndrome: An Update Based on the Revised AWMF-S2k Guideline	1
Diagnosing Inherited Platelet Disorders: Modalities and Consequences	1
Markers of Hereditary Thrombophilia with Unclear Significance	1
Impact of Thrombophilia Testing on Clinical Management: A Retrospective Cohort Study	1
Primary Prevention of Cancer-Associated Thrombosis: Current Perspectives	1
GTH News	1
Pulmonary Embolism: An Update Based on the Revised AWMF-S2k Guideline	1
Digital Technologies in Hereditary Coagulation Disorders: A Systematic Review	1
Pulmonary Embolism: Don't Start Me to Talkin'	1
Cardiovascular Risk Assessment in COVID-19	1
Subsegmental Pulmonary Embolism	1
Acid Treatment of FVIII-Containing Plasma Samples Unmasks a Broad Spectrum of FVIII-Specific Antibodies in ELISA	1
Immune Thrombocytopenia: Characteristics of the Population and Treatment Methods—One-Center Experience	1
Grundlagen zur Anwendung von Andexanet	0
Conformational opening of ADAMTS13 does not necessarily indicate preactivation of its metalloprotease domain	0
Die Gesellschaft für Thrombose- und Hämostaseforschung e.V. informiert	0
Pathophysiology of Trauma-Induced Coagulopathy	0
Cardiac and Cerebral Arterial Complications of Lemierre Syndrome: Results from a Systematic Review and Individual Patient Data Meta-analysis	0
Intrinsic Activated Thrombin Generation for Efficacy and Monitoring of Factor VIII Replacements and Mimetics	0
Intermediate- and high-risk pulmonary embolism in pediatric tertiary care centers in the Netherlands. Is there a need for a pediatric PERT?	0
Update on Tissue Factor Detection in Blood in 2024: A Narrative Review	0
Factor XI as a Target for New Anticoagulants	0
Clinical laboratories need more information about commercially available reagents to prepare to IVDR: A call from ICSH	0
Crosstalk between platelets and red blood cells promotes abdominal aortic aneurysm formation and progression	0
Thrombozyten: Blutstillung ohne Gerinnselbildung	0
Pitfalls in Coagulation Testing	0
Potenzielle globale Gerinnungsparameter für Therapiemonitoring unter Emicizumab	0
Direct Oral Anticoagulants: Laboratory Challenges and Antidotes	0
Management of Vascular Thrombosis in Patients with Thrombocytopenia	0
Vakzin-induzierte Immunthrombozytopenie und Thrombose: Langfristiger Outcome	0
Anticoagulation in Pediatric Patients	0
Enhancing Anticoagulation Monitoring and Therapy in Patients Undergoing Microvascular Reconstruction in Maxillofacial Surgery: results from the interims analysis of the prospective study	0
THROMKIDplus Patient Registry and Biomaterial Banking for Children with Inherited Platelet Disorders	0
Veranstaltung des BDDH im Rahmen der 67. Jahrestagung der Gesellschaft für Thrombose- und Hämostaseforschung in Frankfurt	0
Plasma levels and Reversal strategies in 100 consecutive DOAC emergencies – a single center case series	0

Management of Deep Vein Thrombosis: An Update Based on the Revised AWMF S2k Guideline	0
	0
Circulating Tumor Cells and Thromboembolic Events in Patients with Glioblastoma	0
Development and evaluation of a novel machine learning algorithm for outpatient thrombophilia diagnosis, management, and venous thrombosis risk stratification	0
Probable Catastrophic Antiphospholipid Syndrome in a Patient with Immune Thrombocytopenia Treated with a Thrombopoietin Receptor Agonist	0
Oral Anticoagulation and Mortality in Cases with Intracranial Bleeding: Analysis of Nationwide Prescription and Hospitalization Data	0
	0
Intensive lifestyle intervention on thrombin generation in individuals at high risk for type 2 diabetes	0
Platelets and COVID-19	0
	0
Current Diagnostic and Therapeutic Approaches in May–Thurner Syndrome in Children, Adolescents, and Young Adults: A Survey among Thrombosis Experts of the German Society of Thrombosis and Haemostasis	0
The Diagnostic Approach to Inherited Mild (to Moderate) Bleeding Disorders: A Current Perspective	0
Platelets and Matrix Metalloproteinases: A Bidirectional Interaction with Multiple Pathophysiologic Implications	0
Congenital Fibrinogen Deficiencies: Not So Rare	0
A Novel Fibrinogen Mutation p.BβAla68Asp Causes an Inherited Dysfibrinogenemia	0
COVID-19 and the Incidence of Acute Myocardial Injury	0
Im letzten Augenblick verhindert: Geplante Übertragung der Richtlinienbefugnis bezüglich Herstellung und Anwendung von Blut und Blutprodukten von der Bundesärztekammer (BÄK) auf das Paul-Ehrlich-Insti	0
Fibrinogen Bonn (p. Arg510Cys) in the Aα-Chain Is Associated with High Risk of Venous Thrombosis	0
	0
Classic Light Transmission Platelet Aggregometry: Do We Still Need it?	0
Reform des Kapitels 32 (Laboratoriumsmedizin) im einheitlichen Bewertungsmaßstab (EBM)	0
Inhibition of MicroRNA-122-5p Relieves Myocardial Ischemia-Reperfusion Injury via SOCS1	0
Venous Thrombosis and SARS-CoV-2	0
Post Partum Haemorrhage: prepartum plasmin and thrombin generation is similar in women with and without PPH	0
Downregulation of VWF promotes myosin light chain phosphorylation and induces endothelial barrier dysfunction	0
Investigations on the Hemostatic Potential of Physiological Body Fluids	0
	0
	0
Endometriose steigert Risiko für venöse Thrombembolien unter oraler Kontrazeption	0
Novel Perspectives on Thrombopoietin Receptor Agonists Applications	0
Priv.-Doz. Dr. med. Rainer B. Zotz	0
Neuigkeiten zur Ablösung der geplanten Ablösung der In-Vitro-Diagnostika-Richtlinie durch die In-Vitro-Diagnostika-Verordnung (IVDR) 05/2022 und Plasmaversorgung in Deutschland/EU und Fortführung der	0
From Code to Clots: Applying Machine Learning to Clinical Aspects of Venous Thromboembolism Prevention, Diagnosis, and Management	0
Schwere nächtliche Hypoxie erhöht Wahrscheinlichkeit einer unprovozierten venösen Thromboembolie	0
Management of Recurrent Venous Thromboembolism in Severe Immune Thrombocytopenia: A Case Report and a Review of the Literature	0
Experiences in Routine Genetic Analysis of Hereditary Hemorrhagic, Thrombotic, and Platelet Disorders	0
Normal APC-resistance phenotype in a case of FV Leiden mutation along with F5-deficiency due to c.5017C>T genotype	0
Acquired von Willebrand Syndrome in Children	0
Factor XIII and Endothelial Dysfunction in Patients with Systemic Sclerosis	0
Bleeding Risk in Patients with Cancer	0
When and How to Combine Antiplatelet and Anticoagulant Drugs?	0
NBEAL2 related Gray Platelet Syndrome with a combined platelet granules secretion defect in flow cytometry	0
High Prevalence of F2 20210G > A in Splanchnic Vein Thrombosis and Cerebral Venous Sinus Thrombosis: A Retrospective Cohort Study of Patients with Thrombosis in Atypical Sites	0
Multisite Thrombosis in a Patient with Paroxysmal Nocturnal Hemoglobinuria	0
Recognizing inherited platelet disorders on the peripheral blood smear by immunofluorescence microscopy: results of the first international workshop	0
GTH 2023: The Patient as a Benchmark	0
Facial Hematoma: An Atypical Bleeding Site for Acquired Hemophilia	0
Challenging Situations in the Treatment of Cancer-Associated Thrombosis	0
Clopidogrel reduziert Infarktrisiko	0
The Use of DOACs in Pediatrics: Current Therapeutic and Prophylactic Indications, Cardiac Indications, and Real-World Evidence—A Review	0
Adaptable imMKCL-based approach to study the variety of megakaryocyte and platelet mutations	0
	0
Intravital Imaging of Thrombosis Models in Mice	0
Correlation between Platelet-to-Lymphocyte Ratio, Neutrophil-to-Lymphocyte Ratio and Burden of Thrombus with Disease Severity in Patients with Pulmonary Thromboembolism	0
Erratum: A Novel Fibrinogen Mutation p.BβAla68Asp Causes an Inherited Dysfibrinogenemia	0
Platelets and Sera from Donors of Convalescent Plasma after Mild COVID-19 Show No Procoagulant Phenotype	0
Nonfactor Therapies: New Approaches to Prophylactic Treatment of Haemophilia	0
Baseline Platelet Count Predicts Infarct Size and Mortality after Acute Myocardial Infarction	0
A Cross-sectional Analysis of Treatment in PUPs in 2021 in Germany – First Data from the GEPHARD Study Group	0
Detection of Anti-drug Antibodies in Patients with Acquired Hemophilia A: Data from the GTH-AHA-EMI Study	0
Inflammation, Sepsis, and the Coagulation System	0
Pathogenic Aspects of Inherited Platelet Disorders	0
	0
Apixaban for thromboprophylaxis in paediatric cardiology patients – Real-world data from a single institution	0
Hemostatic and inflammatory biomarkers are associated with functional limitations after venous thromboembolism: Results from a prospective cohort study	0
Clot-Wave-Analyse könnte individualisierte Therapie bei Hämophilie A verbessern	0
	0
Progress in Hemostasis (Part 1): Improved Management of Inherited Platelet Disorders: Reality or Illusion?	0
Compassionate use of osocimab in preventing thrombotic complications without incremental bleeding: a case report	0
Anticoagulation in Patients with Platelet Disorders	0
Von Willebrand Disease—Specific Aspects in Women	0
P2Y12-Inhibitoren hemmen Thrombozyten-induzierte Monozytenaktivierung	0
Non–Vitamin K Antagonist Oral Anticoagulants in Coronary Artery Disease	0
Long-term Outcomes With Efanesoctocog Alfa Prophylaxis for Previously Treated Children With Severe Hemophilia A, an Interim Analysis of the Phase 3 XTEND-ed Study	0
Expression and Release of Tumor Cell Tissue Factor Triggers Recurrent Thromboembolism in a Patient with Endometrial Cancer	0
Type 2 Diabetes: Platelets and Long-Term Metabolic Control as Estimated from Glycosylated Haemoglobin (HbA1c)	0
	0
Sustained Efficacy of Marstacimab in Adults and Adolescents with Severe Hemophilia A or B without Inhibitors	0
	0
Spontaneous Intra-abdominal Hemorrhage in a Hemophilia A Patient Masquerading as Intra-abdominal Pseudotumor	0
DOAC-Dipstick: Algorithmus zum raschen Ausschluss klinisch relevanter Plasmaspiegel von direkten oralen Antikoagulanzien	0
Laboratory Findings, Medical Imaging, and Clinical Outcome in Children with Cerebral Sinus Venous Thrombosis	0
Hypercoagulability combined with routine laboratory parameters accurately predicts liver cirrhosis decompensation	0
Update on Thrombosis Risk in Patients with Cancer: Focus on Novel Anticancer Immunotherapies	0
Petition „Vergütung für medizinische Leistungen – Verbesserung der Rahmenbedingungen für die ambulante Versorgung“, ATMP-QS-Richtlinie Hämophilie und aktueller Stand zur Digitalisierung im Gesundheits	0
Controlling Patient Multiple Electrode Aggregometry Results with Blood Samples of Blood Donors Improves Clinical Interpretation	0
Antithrombotic Treatment for Left Ventricular Assist Devices: One Does Not Fit All	0
Management of Adult Patients with Newly Diagnosed or Relapsed Primary Immune Thrombocytopenia in Eastern Austria	0
In-vitro Evaluation of Anti-PEG Antibody Effects on the Activation of PEGylated Therapeutic FVIII and FIX Products	0
GTH News	0
Extensive Thromboembolism in a Young Male with Asymptomatic COVID-19 Infection and Heterozygous Factor V Leiden Mutation	0
Gentherapie der Hämophilie: Empfehlung der Gesellschaft für Thrombose- und Hämostaseforschung (GTH)	0
Runder Tisch zum deutschen Hämophilieregister (DHR), drohender Praxenkollaps, Stand und Zukunft der ambulanten hämostaseologischen Versorgung in Deutschland	0
	0
Ablösung der In-Vitro-Diagnostika-Richtlinie auf die In-Vitro-Diagnostika-Verordnung (IVDR) 05/2022 und Programm für die BDDH-Veranstaltung im Rahmen des GTH-Kongresses 2022 in Leipzig	0